Walmart launches low-cost private insulin for diabetes patients
Fox Business Flash top headlines for June 29
Check out what’s clicking on FoxBusiness.com.
Walmart has launched a private brand of analog insulin, the company announced Tuesday. The insulin injection, manufactured by Novo Nordisk, and FlexPen, offered through Walmart’s ReliOn brand, will be available in the stores' pharmacies this week.
The company claims the new offering will reap significant savings, at about 58% to 75% off the cash price, or $101 per vial or $251 per package of FlexPens .
Stocks in this Article
"We know many people with diabetes struggle to manage the financial burden of this condition, and we are focused on helping by providing affordable solutions," Dr. Cheryl Pegus, executive vice president, Walmart Health & Wellness, said in a statement posted Tuesday. "We also know this is a condition that disproportionately impacts underserved populations. With ReliOn NovoLog® insulin, we’re adding a high-quality medication for diabetes to the already affordable ReliOn line of products and continuing our commitment to improve access and lowering cost of care."
Over 34 million people in the U.S. have diabetes, with 1 in 4 unaware of it, according to the Centers for Disease Control and Prevention (CDC). Risk factors for Type 2 diabetes include age, family history, smoking, weight, poor diet and insufficient exercise.
KIDS' HOSPITALIZATION RATES FOR TYPE 2 DIABETES MORE THAN DOUBLED DURING PANDEMIC, STUDY SHOWS